CN Bio Innovations, an expert in developing human biomimetic platforms to test and develop therapeutics for liver diseases and infection, is pleased to announce that it has embarked on a research collaboration with RNAi-based therapeutics company, Benitec Biopharma Limited (ASX:BLT).
filed under: Press releasesUpdate: News
- Press releases
- 19 July 2018
- CN Bio Innovations’ Board names David Hughes as next Chief Executive Officer
- Business
- 19 June 2018
- Organ-on-Chip Webinar: Improving Preclinical Studies for Faster Drug Development
Meet Us: Events
- 9-10 Oct 2018
- ELRIG Drug Discovery 2018
- London, UK
- 31 OCT - 1 NOV 2018
- Lab Innovation 2018
- Birmingham, UK
- 5 - 7 NOV 2018
- BioEurope
- Copenhagen, Denmark